Options for improving effectiveness of rotavirus vaccines in developing countries

References

• Tate JE, Burton AH, Boschi-Pinto C, Steele AD, Duque J, Parashar U. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:136-41; PMID:22030330; https://doi.org/http://dx.doi.org/10.1016/S1473-3099(11)70253-5
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rotavirus vaccines. WHO position paper- January 2013. Wkly Epidemiol Rec 2013; 88:49-64; PMID:23424730
   PubMedGoogle Scholar
• Tate JE, Burton AH, Boschi-Pinto C, Parashar UD. Global, regional, and national estimates of rotavirus mortality in children. Clin Infect Dis 2016; 62:S96-105; PMID:27059362; https://doi.org/http://dx.doi.org/10.1093/cid/civ1013
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007; 82:285-95; PMID:17691162
   PubMedGoogle Scholar
• World Health Organization. Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009; 84:533-37; PMID:20034143
   PubMedGoogle Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet 2014; 383:2136-43; https://doi.org/http://dx.doi.org/10.1016/S0140-6736(13)62630-6
   PubMed Web of Science ®Google Scholar
• Armah GE, Kapikian AZ, Vesikari T, Cunliffe N, Jacobson RM, Burlington DB, Ruiz LP. Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period. J Infect Dis 2013; 208:423-31; PMID:23599316; https://doi.org/http://dx.doi.org/10.1093/infdis/jit174
   PubMed Web of Science ®Google Scholar
• Qadri F, Bhuiyan TR, Sack DA, Svennerholm A. Immune responses and protection in children in developing countries induced by oral vaccines. Vaccine 2013; 31:452-60; PMID:23153448; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2012.11.012
   PubMed Web of Science ®Google Scholar
• Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009; 200:S39-48; https://doi.org/http://dx.doi.org/10.1086/605035
   PubMedGoogle Scholar
• Desselberger U, Huppertz HI. Immune responses to rotavirus infection and vaccination and associated correlates of protection. J Infect Dis 2011; 203:188-95; PMID:21288818; https://doi.org/http://dx.doi.org/10.1093/infdis/jiq031
   PubMed Web of Science ®Google Scholar
• Clarke E, Desselberger U. Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol 2015; 8:1-17; PMID:25465100; https://doi.org/http://dx.doi.org/10.1038/mi.2014.114
   PubMed Web of Science ®Google Scholar
• Greenberg HB, Estes MK. Rotaviruses: from pathogenesis to vaccination. . Gastroenterology 2009; 136:1939-51; PMID:19457420; https://doi.org/http://dx.doi.org/10.1053/j.gastro.2009.02.076
   PubMed Web of Science ®Google Scholar
• Banyai K, Laszlo B, Duque J, Steele AD, Nelson EA, Gentsch JR, Parashar UD. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. Vaccine 2012; 30:A122-30; PMID:22520121; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2011.09.111
   PubMed Web of Science ®Google Scholar
• Franco MA, Angel J, Greenberg HB. Immunity and correlates of protection for rotavirus vaccines. Vaccine 2006; 24:2718-31; PMID:16446014; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2005.12.048
   PubMed Web of Science ®Google Scholar
• Patel M, Glass RI, Jiang B, Santosham M, Lopman B, Parashar U. A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis 2013; 208:284-94; PMID:23596320; https://doi.org/http://dx.doi.org/10.1093/infdis/jit166
   PubMed Web of Science ®Google Scholar
• Paul A, Gladstone BP, Mukhopadhya I, Kang G. Rotavirus infections in a community based cohort in Vellore, India. Vaccine 2014; 32S:A49-54; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2014.03.039
   Web of Science ®Google Scholar
• Cherian T, Wang S, Mantel C. Rotavirus vaccines in developing countries: the potential impact, implementation challenges, and remaining questions. Vaccine 2012; 30S:A3-A6; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2011.10.007
   Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Eng J Med 2006; 354:23-33; PMID:16394299; https://doi.org/http://dx.doi.org/10.1056/NEJMoa052664
   PubMed Web of Science ®Google Scholar
• Block SL, Vesikari T, Goveia MG, Rivers SB, Adeyi BA, Dallas MJ, Bauder J, Boslego JW, Heaton PM. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant Rotavirus vaccine at the end of shelf life. Pediatrics 2007; 119:11-8; PMID:17200266; https://doi.org/http://dx.doi.org/10.1542/peds.2006-2058
   PubMed Web of Science ®Google Scholar
• Goveia MG, DiNubile MJ, Dallas MJ, Heaton PM, Kuter BJ, Team RS. Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency. Pediatr Infect Dis J 2008; 27:656-8; PMID:18520448; https://doi.org/http://dx.doi.org/10.1097/INF.0b013e318168d29e
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velázquez FR, Abate H, Breuer T, Costa Clemens S, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Eng J Med 2006; 354:11-22; PMID:16394298; https://doi.org/http://dx.doi.org/10.1056/NEJMoa052434
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, Meurice F, Han HH, Damaso S, Bouckenooghe A. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007; 370:1757-63; PMID:18037080; https://doi.org/http://dx.doi.org/10.1016/S0140-6736(07)61744-9
   PubMed Web of Science ®Google Scholar
• Clark HF, Burke CJ, Volkin DB, Offit P, Ward RL, Bresee JS, Dennehy P, Gooch WM, Malacaman E, Matson D. Safety, immunogenicity, and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation. Pediatr Infect Dis J 2003; 22:914-20; PMID:14551493; https://doi.org/http://dx.doi.org/10.1097/01.inf.0000091887.48999.77
   PubMed Web of Science ®Google Scholar
• Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ, et al. Safety, efficacy and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 2004; 144:184-90; PMID:14760258; https://doi.org/http://dx.doi.org/10.1016/j.jpeds.2003.10.054
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, Binka FN, Steele AD, Laserson KF, Ansah NA, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14; PMID:20692030; https://doi.org/http://dx.doi.org/10.1016/S0140-6736(10)60889-6
   PubMed Web of Science ®Google Scholar
• Armah GE, Breiman RF, Tapia MD, Dallas MJ, Neuzil KM, Binka FN, Sow SO, Ojwando J, Ciarlet M, Steele AD. Immunogenicity of the pentavalent rotavirus vaccine in African infants. Vaccine 2012; 30:A86-93; PMID:22520142; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2011.10.006
   PubMedGoogle Scholar
• Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, Podder G, Vu DT, Le TP, Luby SP, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:615-23; PMID:20692031; https://doi.org/http://dx.doi.org/10.1016/S0140-6736(10)60755-6
   PubMed Web of Science ®Google Scholar
• Shin S, Anh DD, Zaman K, Yunus M, Mai LTP, Thiem VD, Azim T, Victor JC, Dallas MJ, Steele AD, et al. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam. Vaccine 2012; 30:A106-13; PMID:22520119; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2011.11.091
   PubMedGoogle Scholar
• Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Eng J Med 2010; 362:289-98; PMID:20107214; https://doi.org/http://dx.doi.org/10.1056/NEJMoa0904797
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Zaman K, Victor JC. A proposed framework for evaluating and comparing efficacy estimates in clinical trials of new rotavirus vaccines. Vaccine 2014; 32:A179-84; PMID:25091673; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2014.04.074
   PubMed Web of Science ®Google Scholar
• Soares-Weiser K, Maclehose H, Bergman H, Ben-Aharon I, Nagpal S, Goldberg E, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2012; 11:CD008521
   PubMed Web of Science ®Google Scholar
• Khin-Maung U, Bolin TD, Duncombe VM, Myo-Khin Nyunt-Nyunt-Wai, Pereira SP, Linklater JM. Epidemiology of small bowel bacterial overgrowth and rice carbohydrate malabsorption in Burmese (Myanmar) village children. Am J Trop Med Hyg 1992; 47:298-304; PMID:1388002
   PubMed Web of Science ®Google Scholar
• dos Reis JC, de Morais MB, Oliva CA, Fagundes-Neto U. Breath hydrogen test in the diagnosis of environmental enteropathy in children living in an urban slum. Dig Dis Sci 2007; 52:1253-8; PMID:17372830
   PubMed Web of Science ®Google Scholar
• Salazar-Lindo E, Allen S, Brewster DR, Elliott EJ, Fasano A, Phillips AD, Sanderson IR, Tarr PI. Intestinal infections and environmental enteropathy: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39:S662-9; PMID:15184767
   PubMed Web of Science ®Google Scholar
• Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995; 13:310-2; PMID:7631519
   PubMed Web of Science ®Google Scholar
• Valdez Y, Brown EM, Finlay BB. Influence of the microbiota on vaccine effectiveness. Trends Immunol 2014; 35:526-37; PMID:25113637
   PubMed Web of Science ®Google Scholar
• Taniuchi M, Platts-Mills JA, Begum S, Uddin MJ, Sobuz SU, Liu J, Kirkpatrick BD, Colgate ER, Carmolli MP, Dickson DM, et al. Impact of enterovirus and other enteric pathogens on oral polioand rotavirus vaccine performance in Bangladeshi infants. Vaccine 2016; 34:3068-75; PMID:27154394
   PubMed Web of Science ®Google Scholar
• Moon SS, Tate JE, Ray P, Dennehy P, Archary D, Coutsoudis A, Bland R, Newell ML, Glass RI, Parashar U, et al. Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr Infect Dis J 2013; 32:863-70; PMID:23584581
   PubMed Web of Science ®Google Scholar
• Groome MJ, Moon SS, Velasquez D, Jones S, Koen A, van Niekerk N, Jiang B, Parashar UD, Madhi SA. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ 2014; 92:238-45; PMID:24700991
   PubMed Web of Science ®Google Scholar
• Rongsen-Chandola T, Strand TA, Goyal N, Flem E, Rathore SS, Arya A, Winje BA, Lazarus R, Shanmugasundaram E, Babji S, et al. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants. Vaccine 2014; 32:A134-9; PMID:25091668
   PubMed Web of Science ®Google Scholar
• Bautista-Marquez A, Velasquez DE, Esparza-Aguilar M, Luna-Cruz M, Ruiz-Moran T, Sugata K, Jiang B, Parashar UD, Patel M, Richardson V. Breastfeeding linked to the reduction of both rotavirus shedding and IgA levels after Rotarix immunization in Mexican infants. Vaccine 2016; 34:5284-89; PMID:27663670
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Sentz J, Miller MA. Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis. Pediatrics 2007; 119:1120-30; PMID:17545379
   PubMed Web of Science ®Google Scholar
• Sazawal S, Black RE, Menon VP, Dinghra P, Caulfield LE, Dhingra U, Bagati A. Zinc supplementation in infants born small for gestational age reduces mortality: a prospective, randomized, controlled trial. Pediatrics 2001; 108:1280-6; PMID:11731649
   PubMed Web of Science ®Google Scholar
• Zhao N, Wang X, Zhang Y, Gu Q, Huang F, Zheng W, Li Z. Gestational zinc deficiency impairs humoral and cellular immune responses to hepatitis B vaccination in offspring mice. PloS One 2013; 8:e73461; PMID:24069198
   PubMed Web of Science ®Google Scholar
• Rose J, Hawthorn RL, Watts B, Singer ME. Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis. BMJ 2009; 339:1-12
   Web of Science ®Google Scholar
• Levine MM. Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine. BMC Biol 2010; 8:129; PMID:20920375
   PubMed Web of Science ®Google Scholar
• Status of vaccine research and development of next-generation rotavirus vaccines. WHO Product Development for Vaccines Advisory Committee Meeting. Geneva, Switzerland, 2014
   Google Scholar
• Bines JE, Danchin M, Jackson P, Handley A, Watts E, Lee KJ, West A, Cowley D, Chen MY, Barnes GL, et al. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2015; 15:1389-97; PMID:26318715
   PubMed Web of Science ®Google Scholar
• Dhingra MS, Kundu R, Gupta M, Kanungo S, Ganguly N, Singh MP, Bhattacharya MK, Ghosh R, Kumar R, Sur D, et al. Evaluation of safety and immunogenicity of a live attenuated tetravalent (G1–G4) Bovine-Human Reassortant Rotavirus vaccine (BRV-TV) in healthy Indian adults and infants. Vaccine 2014; 32S:A117-23
   Web of Science ®Google Scholar
• Bernal A. Shantha's Investigational Rotavirus Vaccine Enters Phase III Clinical Trials in India. Sanofi Pasteur 2014
   Google Scholar
• Zade JK, Kulkarni PS, Desai SA, Sabale RN, Naik SP, Dhere RM. Bovine rotavirus pentavalent vaccine development in India. Vaccine 2014; 32:A124-8; PMID:25091665
   PubMed Web of Science ®Google Scholar
• Estes M, Khan G, Neuzil K, Parashar U, Steele AD. Developing next generation rotavirus vaccines. In: Organization WH, ed. Global Vaccine and Immunization Research Forum. Bethesda, MD 2014
   Google Scholar
• Fix AD, Harro C, McNeal M, Dally L, Flores J, Robertson G, Boslego JW, Cryz S. Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults. Vaccine 2015; 33:3766-72; PMID:26065919
   PubMed Web of Science ®Google Scholar
• Kim S, Jang Y. Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp Mol Med 2014; 46:e85; PMID:24626171
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11:S45-53; PMID:15812489
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C, Eriksson K, Mharandi A. Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges. Vaccine 2003; 21:89-95
   PubMed Web of Science ®Google Scholar
• Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ 1999; 77:789-800; PMID:10593026
   PubMed Web of Science ®Google Scholar
• Levine MM. Can needle-free administration of vaccines become the norm in global immunization? Nat Med 2003; 9:99-103; PMID:12514720
   PubMed Web of Science ®Google Scholar
• Aguilar JC, Rodriguez EG. Vaccine adjuvants revisited. Vaccine 2007; 25:3752-62; PMID:17336431
   PubMed Web of Science ®Google Scholar
• Schijns VE. Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants. Vaccine 2003; 21:829-31; PMID:12547589
   PubMed Web of Science ®Google Scholar
• Schijns VE. Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 2000; 12:456-63; PMID:10899018
   PubMed Web of Science ®Google Scholar
• Hawken J, Troy SB. Adjuvants and Inactivated Polio Vaccine: A Systematic Review. Vaccine 2012; 30:6971-79; PMID:23041122
   PubMed Web of Science ®Google Scholar
• Zhang W, Azevado M, Wen K, Gonzalez A, Saif LJ, Li G, Yousef AE, Yuan L. Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs. Vaccine 2008; 26:3655-61; PMID:18524434
   PubMed Web of Science ®Google Scholar
• Rossignol JF. Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antiviral Res 2014; 110:94-103; PMID:25108173
   PubMed Web of Science ®Google Scholar
• Fox LM, Saravolatz LD. Nitazoxanide: a new thiazolide antiparasitic agent. Clin Infect Dis 2005; 40:1173-80; PMID:15791519
   PubMed Web of Science ®Google Scholar
• Haffizulla J, Hartman A, Hoppers M, Resnick H, Samudrala S, Ginocchio C, Bardin M, Rossignol JF. Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial. Lancet Infect Dis 2014; 14:609-18; PMID:24852376
   PubMed Web of Science ®Google Scholar
• Rossignol JF, Abu-Zekry M, Hussein A, Santoro MG. Effect of nitazoxanide for treatment of severe rotavirus gastroenteritis diarrhoea: randomised double-blind placebo-controlled trial. Lancet 2006; 368:124-9; PMID:16829296
   PubMed Web of Science ®Google Scholar
• Teran CG, Teran-Escalera CN, Villarroel P. Nitazoxanide vs. probiotics for the treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children. Int J Infect Dis 2009; 13:518-23; PMID:19070525
   PubMed Web of Science ®Google Scholar
• A randomised, placebo-controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Indigenous children. In: Council AGNHaMR, ed.: Commonwealth of Australia, 2016
   Google Scholar
• La Frazia S, Ciucci A, Arnoldi F, Coira M, Gianferretti P, Angelini M, Belardo G, Burrone OR, Rossignol JF, Santoro MG. Thiazolides, a new class of antiviral agents effective against rotavirus infection, target viral morphogenesis, inhibiting viroplasm formation. J Virol 2013; 87:11096-106; PMID:23926336
   PubMed Web of Science ®Google Scholar
• Clerici M, Trabattoni D, Pacei M, Biasin M, Rossignol JF. The antiinfective nitazoxanide shows strong immuno-modulating effects [abstract]. J Immunol 2011; 186:21
   Google Scholar
• World Health Organization. Polio vaccines: WHO position paper, January 2014. Wkly Epidemiol Rec 2014; 89:73-92; PMID:24707513
   PubMedGoogle Scholar
• Danchin MH, Kirkwood CD, Lee KJ, Bishop RF, Watts E, Justice FA, Clifford V, Cowley D, Buttery JP, Bines JE. Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. Vaccine 2013; 31:2610-6; PMID:23597719
   PubMed Web of Science ®Google Scholar
• Clark A, Sanderson C. Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet 2009; 373:1543-9; PMID:19303633
   PubMed Web of Science ®Google Scholar
• Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, Gambhir M, Atchison C, Grenfell BT, Edmunds WJ, et al. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One 2012; 7:e41720; PMID:22879893
   PubMed Web of Science ®Google Scholar